Clinical Trials Browser

NIH × Stomach Neoplasms × Bevacizumab × Clear all

NCT00084604 2013-06-04

Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms